BUSINESS

It’s the end of Biovail as we know it

STEVE MAICH December 25 2006
BUSINESS

It’s the end of Biovail as we know it

STEVE MAICH December 25 2006

Happy Birthday

AstraZeneca

We can't make any promises, but we'll keep trying. With products in the therapeutic areas of cardiovascular, gastrointestinal, oncology, respiratory, neuroscience and infection, and with more than $100 million committed each year to research in Canada, who knows where that can lead?